Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies?

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	1017-1020
Number of pages	4
Journal	Immunotherapy
Volume	6
Issue number	10
DOIs	https://doi.org/10.2217/imt.14.87
State	Published - Oct 1 2014

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

Access to Document

10.2217/imt.14.87

Cite this

@article{7fdfc02af60b41d09b08df2e16850bde,

title = "Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies?",

author = "Lei Zheng",

year = "2014",

month = oct,

day = "1",

doi = "10.2217/imt.14.87",

language = "English (US)",

volume = "6",

pages = "1017--1020",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Future Medicine Ltd.",

number = "10",

}

TY - JOUR

T1 - Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies?

AU - Zheng, Lei

PY - 2014/10/1

Y1 - 2014/10/1

UR - http://www.scopus.com/inward/record.url?scp=84913612431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913612431&partnerID=8YFLogxK

U2 - 10.2217/imt.14.87

DO - 10.2217/imt.14.87

M3 - Review article

C2 - 25428641

AN - SCOPUS:84913612431

VL - 6

SP - 1017

EP - 1020

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 10

ER -